UNSPSC 51313707: Bosentan monohydrate

This classification denotes an endothelin receptor antagonist with the molecular formula C27H29N5O6S.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q326023R30, chemically known as 4-(1,1-dimethylethyl)-n-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2-bipyrimidin)-4-yl)benzenesulfornamide but more generally known as bosentan, which bears US NIH Compound Identifier 104865. Bosentan most often comes in basic and hydrate forms.

UNSPSC 51313707 Bosentan monohydrate is a Commodity code that shows little relevant recent activity in state and local procurement. The sole recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—does not align with bosentan monohydrate, a pharmaceutical used to treat pulmonary arterial hypertension. The mismatch suggests either a miscategorization in the county's tagging or a data error in the underlying opportunity record. Bosentan monohydrate itself, a specialty pharmaceutical, would typically be procured through pharmacy benefit managers, health system formularies, or direct hospital purchasing rather than general competitive bidding processes like the one shown here.

Without additional opportunities properly aligned to this Commodity code, no clear pattern of state and local buying activity, issuing-body concentration, or geographic spread can be discerned. Business development professionals evaluating this code should treat it as inactive for state and local procurement purposes unless subsequent opportunities demonstrate genuine demand for bosentan monohydrate under this UNSPSC tag.